NEW YORK – (BUSINESS WIRE) – February 25, 2021–
Today, RubiconMD, the leading eConsult platform providing access to specialist knowledge, is launching a range of COVID-19 vaccine resources to continue helping GPs throughout the pandemic. Doctors can submit eConsults to the RubiconMD Panel of COVID-19 Vaccine Experts, review real eConsult case studies submitted on the platform, and take advantage of a range of educational resources developed in partnership with the CONVINCE USA initiative at the CUNY Graduate School of Public Health and Health Policy .
In a survey of RubiconMD clinicians, 50% of respondents felt they did not have the resources to make vaccine decisions to adequately answer patient questions. Respondents strongly emphasized the need for digestible summaries of vaccine recommendations, clinical guidelines for patients with complex diseases, and multilingual resources for patients.
“Our country is still in crisis. A fair and prompt distribution of the COVID-19 vaccine is key to returning to normal, ”said Dr. Celine Gounder, infectious disease expert and member of the COVID-19 Advisory Board at Biden-Harris Transition. “When it comes to their health, patients trust their GPs more than any other source of information. Basic services are critical to vaccinating our country, and a resource like RubiconMD to support basic services is invaluable. “
“As the COVID-19 situation evolves, clinicians need to understand the overwhelming amount of new clinical information and translate that into the best care for their patients,” said Gil Addo, Co-Founder and CEO of RubiconMD. “PCPs have relied on RubiconMD’s insights for years, and we are committed to meeting their needs during the COVID-19 pandemic.”
In light of this feedback, RubiconMD encourages clinicians to reach out to their specialists with any questions about vaccines, and to use the dashboard for constantly updated curated content and CME-enabled webinars.
“We are encouraged to see an increasing wave of COVID-19 vaccine adoption across all communities, but it is imperative that we seize this opportunity with education and vaccine access. This platform ensures that GPs can deliver the clear and accurate communication that is critical to tackling a complex pandemic, ”said Dr. Ayman El-Mohandes, Dean of CUNY SPH and Contributing Director of CONVINCE USA.
About RubiconMD
Founded in 2013, RubiconMD continues its mission to democratize medical expertise by connecting primary care clinicians with top specialists. Through its digital platform, RubiconMD enables the remote sharing of insights between clinicians, avoiding unnecessary referrals and services, reducing waiting times and travel costs for patients, and allowing primary care to be practiced at the top of their license. For more information, please visit www.rubiconmd.com.
About CONVINCE USA
The CONVINCE USA (COVID-19 New Vaccine Information, Communication and Engagement) initiative at the New York University Graduate School of Public Health and Public Health (CUNY SPH) is part of a global coalition to advance vaccine literacy in general. and especially confidence in COVID-19 vaccines. Its mission is to achieve sufficient global vaccine adoption and the level of population immunity needed to contain the COVID-19 pandemic by working in a coordinated manner with partners to deliver clear, scientific and accessible information provide. For more information, please visit https://sph.cuny.edu/research/convince/.
About CUNY SPH
The CUNY Graduate School of Public Health and Public Health (CUNY SPH) is committed to teaching, research and services that create a healthier New York City and help promote equitable, efficient, and evidence-based solutions to pressing health problems in cities around the world World. Located in Harlem, CUNY SPH is the premier public health school in New York City, New York State, and the Tristate region.
Show source version on businesswire.com::https://www.businesswire.com/news/home/20210225005231/de/
CONTACT: Michele Lee
KEYWORD: NEW YORK UNITED STATES NORTH AMERICA
KEYWORD IN INDUSTRY: INFECTIOUS DISEASES GENERAL HEALTH HEALTH
SOURCE: RubiconMD
Copyright Business Wire 2021.
PUB: 02/25/2021 09:00 am / DISC: 02/25/2021 09:01 am
http://www.businesswire.com/news/home/20210225005231/de
Copyright Business Wire 2021.
